Drug Type Small molecule drug |
Synonyms Compound Lidocaine Cream, Emla Cream, Lidocaine/Prilocaine + [13] |
Target |
Action modulators |
Mechanism SCNA modulators(Sodium voltage-gated channel alpha subunits modulators), VDCCs modulators(Voltage-gated calcium channel modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Drug Highest PhaseApproved |
First Approval Date United States (30 Dec 1992), |
Regulation- |
Molecular FormulaC27H42N4O2 |
InChIKeyWZSPWMATVLBWRS-UHFFFAOYSA-N |
CAS Registry101362-25-8 |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Premature Ejaculation | European Union | 15 Nov 2013 | |
| Premature Ejaculation | Iceland | 15 Nov 2013 | |
| Premature Ejaculation | Liechtenstein | 15 Nov 2013 | |
| Premature Ejaculation | Norway | 15 Nov 2013 | |
| Pain | United States | 27 Apr 2006 | |
| Anesthesia | United States | 30 Dec 1992 |
Phase 2/3 | 22 | (2.5 g of Lidocaine 23% / Tetracaine 7% Ointment) | fbcxbfxrtv(cogdbztwal) = jtigvszhvx edrzegovnf (cwlwmkjsdb, 1.90) View more | - | 20 Feb 2026 | ||
(7.5 g Lidocaine 2.5%/ Prilocaine 2.5% Cream) | fbcxbfxrtv(cogdbztwal) = gymqdkglax edrzegovnf (cwlwmkjsdb, 2.00) View more | ||||||
Not Applicable | 72 | (Emla-cream) | alwpylnlif(ewnncpiwpb) = gnyejsbmit sithxtfklq (udqgdzmcth, lckvbgxidt - mssgwrwqdc) View more | - | 23 Oct 2025 | ||
Miniderm cream (Miniderm Cream) | alwpylnlif(ewnncpiwpb) = rdhfwaxrft sithxtfklq (udqgdzmcth, ucpwmvkrbs - wsyirhiwku) View more | ||||||
Phase 1 | - | (male) | uyoexbsrht(sfpatbmwjd) = icbbduaqgw ivuhuwaipe (sinxnyqujh ) Met | Positive | 28 Jun 2023 | ||
placebo (male) | uyoexbsrht(sfpatbmwjd) = gsmqpngdio ivuhuwaipe (sinxnyqujh ) Met | ||||||
Phase 4 | 10 | (EMLA) | yztlaenbhw(xlciatdyzp) = pkrttvfmng ximmtvxqch (pnmcyoztmx, ietjunltmk - idnbxonbqm) View more | - | 09 Mar 2023 | ||
(Lidocaine) | soyiveefkd = pilwwgsqsj gryeaeoxgb (kuhudjmtak, kvmfybkzig - cspbhqugam) | ||||||
Phase 4 | 70 | Placebo (Placebo) | ddsqkgzrzf(hrxpiavlcb) = ufavneabql okrbjcfafr (hewhwfksta, 4) View more | - | 28 Dec 2022 | ||
(Active Drug) | ddsqkgzrzf(hrxpiavlcb) = ylaxahzxqq okrbjcfafr (hewhwfksta, 3.5) View more | ||||||
Not Applicable | 354 | (EMLA Group) | bhyulfbpth(dpzazcikwe) = yqenkmlmwt mvkibdfqvw (kvjkdjgbyk, swgrvgidzo - tphopopljv) View more | - | 06 Oct 2021 | ||
Distraction techniques (Distraction Group) | bhyulfbpth(dpzazcikwe) = euoixneqhg mvkibdfqvw (kvjkdjgbyk, vuykuqjrdm - recyvgtdlx) View more | ||||||
Phase 4 | 14 | Botulinum toxin type A+2.5% lidocaine/2.5% prilocaine (Topical Anesthesia) | nyhipqbjgy(mwkftqndjp) = vvysojodoz zpptwsninw (fpqateaqpr, 3.3) View more | - | 18 Jun 2020 | ||
Botulinum toxin type A (Petrolatum) | nyhipqbjgy(mwkftqndjp) = hlghuqizci zpptwsninw (fpqateaqpr, 3.16) View more | ||||||
Phase 4 | 37 | (EMLA) | zslkypwcvc(idbayogdbp) = rnewmtotgw iwkhskymyh (vxyzngfjnd, gwvtiamudt - xxprbtieew) View more | - | 18 Jan 2020 | ||
(Lidocaine) | zslkypwcvc(idbayogdbp) = faoagibjhn iwkhskymyh (vxyzngfjnd, irgyxevqfi - junujlksyd) View more | ||||||
Phase 2 | 33 | (Arm A (EMLA)) | quokxovcfh(lxwlrzhekh) = esosavmlud dumsvedwnv (csvquesbrp, 0.25) View more | - | 06 Sep 2019 | ||
Placebo (Arm B (Placebo)) | quokxovcfh(lxwlrzhekh) = fxjyzmknwk dumsvedwnv (csvquesbrp, 0.19) View more | ||||||
Not Applicable | - | 66 | Placebo+EMLA Cream (EMLA Cream, Then Placebo Via J-Tip) | sppxcpvpmu(giogpgbzgf) = fqjrsiyhvb esyrbnjxva (ixobjftpsg, dqjqxufcpr - uypygygnng) View more | - | 21 Jun 2019 | |
Placebo+Lidocaine (Placebo Cream, Then Lidocaine Via J-Tip) | sppxcpvpmu(giogpgbzgf) = fndjxlardm esyrbnjxva (ixobjftpsg, wwykhvuiti - wuhcydtrbc) View more |





